Search
 
1    2    3    4   
Press Releases
Jun 24, 2015
Generex Announces Capital Investment
May 26, 2015
Generex Announces Collaboration with NHTherapeutics to Utilize the RapidMist™ Buccal Delivery Technology for Leuprolide
May 14, 2015
Generex Provides Data Update from AE37 Phase II Breast Cancer Trial One Year Post Completion of Enrollment
All releases
Webcast Events and Media
  Generex Conference Call with Conference Call with Members of the Antigen Express Scientific Advisory Board
- Aug 14, 2013

 

Print Print     Email Email page

News Releases


All Releases
View Summary Generex Announces Capital Investment
Jun 24, 2015
PDF 13.2 KB
View Summary Generex Announces Collaboration with NHTherapeutics to Utilize the RapidMist™ Buccal Delivery Technology for Leuprolide
May 26, 2015
PDF 14.3 KB
View Summary Generex Provides Data Update from AE37 Phase II Breast Cancer Trial One Year Post Completion of Enrollment
May 14, 2015
PDF 13.2 KB
View Summary Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split
May 4, 2015
PDF 15.4 KB
View Summary Generex Announces New $11 Million Collaboration on Buccal Cannabis
Apr 23, 2015
PDF 15.1 KB
View Summary Generex Announces Presentation of Data Correlating Immune Response with Reduction of Relapse in AE37 Phase II Breast Cancer Trial at AACR 2015
Apr 21, 2015
PDF 14.4 KB
View Summary Generex Acknowledges the Contributions of Its Chairman
Apr 7, 2015
PDF 11.5 KB
View Summary Generex Provides Update on Buccal Insulin Formulation Enhancement Project
Mar 12, 2015
PDF 13.6 KB
View Summary Generex Provides Update on Antigen Express Phase II AE37 Breast Cancer Vaccine Trial
Feb 17, 2015
PDF 13.1 KB
View Summary Generex Announces Participation in MedCannAccess® - CannScience Partnership on Non-Smoked Forms of Marijuana
Dec 17, 2014
PDF 13.4 KB
View Summary Generex Announces Collaboration on Medicinal Cannabis
Nov 18, 2014
PDF 12.2 KB
View Summary Generex Announces Presentation at the Society for Immunotherapy of Cancer Demonstrating that Induction of Antibody Response in Patients Receiving the AE37 Breast Cancer Vaccine Correlates with Reduced Relapse
Nov 11, 2014
PDF 12.3 KB
View Summary Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons
Oct 27, 2014
PDF 14.4 KB
View Summary Generex / Antigen Express to Participate in 2014 BIO-Europe® Annual International Partnering Conference
Oct 23, 2014
PDF 13.0 KB
View Summary Generex Announces Publication of Ebola Vaccine White Paper by Antigen Express
Oct 21, 2014
PDF 13.2 KB
View Summary Generex Clarifies Utility of Antigen Express Technology for Potential Ebola Vaccine
Oct 7, 2014
PDF 12.1 KB
View Summary Generex Announces Engagement of Dr. Lakshmi P. Kotra for Buccal Insulin Enhancement Project
Sep 30, 2014
PDF 12.3 KB
View Summary Generex Collaborates with University Health Network for Buccal Insulin Project
Sep 22, 2014
PDF 11.9 KB
View Summary Generex / Antigen Express to Participate in BioPharm America™ 2014
Sep 3, 2014
PDF 12.4 KB
View Summary Generex Announces Publication of AE37 Prostate Cancer Vaccine Study
Aug 6, 2014
PDF 11.6 KB
View Summary Generex Announces Interview of Dr. Eric von Hofe, President of Antigen Express, Following Recent Keynote Presentation
Jun 17, 2014
PDF 12.5 KB
View Summary Generex/Antigen Express Announce Interview of MD Anderson's Dr. Elizabeth Mittendorf, Principal Investigator on Company's AE37 Phase IIb Breast Cancer Efficacy Trial
Jun 12, 2014
PDF 11.8 KB
View Summary Generex / Antigen Express to Participate in 2014 BIO International Convention
Jun 10, 2014
PDF 11.2 KB
View Summary Generex Announces Presentation of Primary Efficacy Data & Immunological Response from the Phase II Study of AE37 Cancer Vaccine at ASCO
May 20, 2014
PDF 12.3 KB
View Summary Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting
Apr 23, 2014
PDF 12.1 KB
View Summary Generex Announces $2,075,000 Capital Investment
Mar 27, 2014
PDF 13.0 KB
View Summary Generex/Antigen Express Announces Participation on Panel at Upcoming Cancer Immunotherapeutics Symposium
Mar 26, 2014
PDF 10.6 KB
View Summary Generex Subsidiary Antigen Express Receives Patents for Vaccines Targeting HPV Induced Cancers and Influenza
Mar 5, 2014
PDF 10.2 KB
View Summary Generex Announces Publication of Biomarker Studies Related to the Antigen Express Novel Immunotherapeutic AE37 in Prostate Cancer Patients
Feb 27, 2014
PDF 11.4 KB
View Summary Generex/Antigen Express Interview on Clear Channel Business Talk Radio DFW 1190AM by Host Michael Yorba
Feb 12, 2014
PDF 14.2 KB
View Summary Generex Provides Update on Antigen Express Phase II AE37 Breast Cancer Vaccine Trial
Feb 12, 2014
PDF 12.1 KB
View Summary Generex/Antigen Express "Stock News Now" Interview Available Online
Feb 4, 2014
PDF 10.5 KB
View Summary Generex Announces Completion of Enrollment of Antigen Express Phase II AE37 Breast Cancer Vaccine Trial
Jan 13, 2014
PDF 12.1 KB
View Summary Generex Announces Selection of Antigen Express Technology for Keynote Presentation at 2014 TIDES Conference
Jan 9, 2014
PDF 12.5 KB
View Summary Generex/Antigen Express Announce Database Lock of AE37 Breast Cancer Vaccine Trial
Jan 6, 2014
PDF 11.6 KB
View Summary Antigen Express AE37 Breast Cancer Vaccine Update
Nov 18, 2013
PDF 11.7 KB
View Summary Generex Provides Update on Generex Oral-lyn™ Conference Call
Sep 27, 2013
PDF 11.6 KB
View Summary Generex Announces Publication of Follow-up Studies from Phase I Trial of Novel Immunotherapeutic in Prostate Cancer Patients
Aug 20, 2013
PDF 11.9 KB
View Summary Generex Announces Podium Presentation on Antigen Express Cancer Vaccine Strategy
Aug 13, 2013
PDF 12.0 KB
View Summary Generex Provides Call-In Details for Conference Call with Members of the Antigen Express Scientific Advisory Board
Aug 12, 2013
PDF 11.0 KB
Showing 1-40 of 550 Page: 1 2 3 4 5 ... 14  Next 40

Privacy Policy